GoldenGolden
Advanced Search
Polaris Venture Capital

Polaris Venture Capital

A venture capital firm in Israel that focuses on technology companies.

Polaris Venture Capital is a venture capital firm in Israel that focuses on technology companies. Founded in Tel Aviv, Israel, it invests in series B, seed rounds, venture rounds, series G, series E and series A rounds. its portfolio companies include NakedPoppy, Lyra Therapeutics, Respicardia, Cardlytics, aTyr Pharma, BarkBox, ClearView Audio, Selecta Biosciences, and Allurent. As of March 2020, Polaris Venture Capital has made 16 investments. Their most recent investment was on March 27, 2019, when NakedPoppy raised $4.1M. Polaris Venture Capital has had seven exits, the most notable of which include Cardlytics, Selecta Biosciences, and aTyr Pharma. Polaris Venture Capital has raised a single venture fund, Polaris Venture Capital Fund III. This fund was announced on May 21, 2000 and raised a total of $500M.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

aTyr Pharma

BarkBox

Cardlytics

Lyra Therapeutics

Respicardia

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.